GlaxoSmithKline PLC's solo flight in the consumer health space features more of the investing and divesting it did while operating the business as the majority owner of a joint venture.
GSK's latest consumer health investment was a $36m upgrade to a Canadian facility, where by mid-2019 it will begin making...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?